Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments.
Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market.
AstraZeneca has followed through on its pledge to provide its COVID-19 vaccine at cost during the pandemic, saying it has agreed to supply 400m doses to the European Inclusive
The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding available to healthcare companies, says a ne